Vildagliptin-Metformin: Is it a causative of cardiac muscle failure in Type 2 Diabetic patients?

• المؤلف الرئيسي: YRKM Sai (مؤلف)
• التنسيق: كتاب
• منشور في: International Journal of Clinical Endocrinology and Metabolism - Peertechz Publications, 2021-09-24.
• الموضوعات: Perspective Study
• الوصول للمادة أونلاين: Connect to this object online.

<p>Vildagliptin is an oral anti-hyperglycaemic agent, commonly called an anti-diabetic medication that belongs to the family of medications known as Dipeptidyl Peptidase-4 (DPP-4) inhibitors. It is a medicine that is used to treat Type 2 Diabetes Mellitus [1]. </p>